Tracking Results with Evenity

Posted by cat1203 @cat1203, Jun 5 8:02am

After nearly 4 years on alendronate, I've had no fractures and my T-scores are stable. Which is not to say good, at least for my spine, which remains at -3.9 Rheumatologist is recommending Evenity. It's my understanding my prior use of alendronate will blunt the effectiveness of Evenity, at least initially. I asked my rheumatologist about bone markers and he doesn't use them. I know not all endos/rheumatologists do so I didn't press the issue. I am not familiar enough with the topic to advocate for their use to track my progress but may later as I learn more. My question to those of you taking Evenity is how, or if, you know it is working for you.

Interested in more discussions like this? Go to the Osteoporosis & Bone Health Support Group.

@cat1203 I would be interested to know whether the doctor recommends a drug holiday without alendronate, and for how long, before starting Evenity. Evenity is so new, that little seems to be known. I might also research Forteo and Tymlos after alendronate, since Evenity is anti-resorptive (like alendronate) for the last 6 months. I have seen a chart on all this somewhere and will try to find it!

REPLY
@windyshores

@cat1203 I would be interested to know whether the doctor recommends a drug holiday without alendronate, and for how long, before starting Evenity. Evenity is so new, that little seems to be known. I might also research Forteo and Tymlos after alendronate, since Evenity is anti-resorptive (like alendronate) for the last 6 months. I have seen a chart on all this somewhere and will try to find it!

Jump to this post

@windyshores he has not recommended a drug holiday before starting any new anabolic--Forteo and Tymlos also are on the table at this point. It will partly/largely depends on what/which my insurance will cover and what co-pays will be, which is still under investigation. Since alendronate stays in the body so long I'm not sure a drug holiday would help mitigate the "blunt" effect.

REPLY
Please sign in or register to post a reply.